Episodic ataxia and severe infantile phenotype in spinocerebellar ataxia type 14: expansion of the phenotype and novel mutations.

Broadened phenotype NGS targeted resequencing panel Novel mutations PRKCG Spinocerebellar ataxia type 14

Journal

Journal of neurology
ISSN: 1432-1459
Titre abrégé: J Neurol
Pays: Germany
ID NLM: 0423161

Informations de publication

Date de publication:
Mar 2022
Historique:
received: 03 04 2021
accepted: 10 07 2021
revised: 08 07 2021
pubmed: 23 7 2021
medline: 23 2 2022
entrez: 22 7 2021
Statut: ppublish

Résumé

Spinocerebellar ataxia type 14 (SCA14) is a dominantly inherited neurological disorder characterized by slowly progressive cerebellar ataxia. SCA14 is caused by mutations in PRKCG, a gene encoding protein kinase C gamma (PKCγ), a master regulator of Purkinje cells development. We performed next-generation sequencing targeted resequencing panel encompassing 273 ataxia genes in 358 patients with genetically undiagnosed ataxia. We identified fourteen patients in ten families harboring nine pathogenic heterozygous variants in PRKCG, seven of which were novel. We encountered four patients with not previously described phenotypes: one with episodic ataxia, one with a spastic paraparesis dominating her clinical manifestations, and two children with an unusually severe phenotype. Our study broadens the genetic and clinical spectrum of SCA14.

Identifiants

pubmed: 34292398
doi: 10.1007/s00415-021-10712-5
pii: 10.1007/s00415-021-10712-5
pmc: PMC8857164
doi:

Substances chimiques

protein kinase C gamma EC 2.7.1.-
Protein Kinase C EC 2.7.11.13

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1476-1484

Subventions

Organisme : AISA
ID : 01.2019
Organisme : Ministero della Salute
ID : RF-2016-02361610
Organisme : E-RARE-3 PREPARE
ID : 3398
Organisme : PROSPAX
ID : 2020
Organisme : Tom Wahlig Foundation
ID : 2020

Informations de copyright

© 2021. The Author(s).

Références

Klebe S, Durr A, Rentschler A, Hahn-Barma V, Abele M, Bouslam N, Schöls L, Jedynak P, Forlani S, Denis E, Dussert C, Agid Y, Bauer P, Globas C, Wüllner U, Brice A, Riess O, Stevanin G (2005) New mutations in protein kinase Cgamma associated with spinocerebellar ataxia type 14. Ann Neurol 58:720–729. https://doi.org/10.1002/ana.20628
doi: 10.1002/ana.20628 pubmed: 16193476
Chelban V, Wiethoff S, Fabian-Jessing BK, Haridy NA, Khan A, Efthymiou S, Becker EBE, O’Connor E, Hersheson J, Newland K, Hojland AT, Gregersen PA, Lindquist SG, Petersen MB, Nielsen JE, Nielsen M, Wood NW, Giunti P, Houlden H (2018) Genotype-phenotype correlations, dystonia and disease progression in spinocerebellar ataxia type 14. Mov Disord 33:1119–1129. https://doi.org/10.1002/mds.27334
doi: 10.1002/mds.27334 pubmed: 29603387 pmcid: 6175136
Koht J, Stevanin G, Durr A, Mundwiller E, Brice A, Tallaksen CM (2014) SCA14 in Norway, two families with autosomal dominant cerebellar ataxia and a novel mutation in the PRKCG gene. Acta Neurol Scand 125:116–122. https://doi.org/10.1111/j.1600-0404.2011.01504.x
doi: 10.1111/j.1600-0404.2011.01504.x
Chen DH, Bird TD, Raskind WH (2005, updated 2020) Spinocerebellar Ataxia Type 14. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2021. Available from: https://www.ncbi.nlm.nih.gov/books/NBK1399/
Chen DH, Brkanac Z, Verlinde CL, Tan XJ, Bylenok L, Nochlin D, Matsushita M, Lipe H, Wolff J, Fernandez M, Cimino PJ, Bird TD, Raskind WH (2003) Missense mutations in the regulatory domain of PKC gamma: a new mechanism for dominant nonepisodic cerebellar ataxia. Am J Hum Genet 72:839–849. https://doi.org/10.1086/373883
doi: 10.1086/373883 pubmed: 12644968 pmcid: 1180348
Stevanin G, Hahn V, Lohmann E, Bouslam N, Gouttard M, Soumphonphakdy C, Welter ML, Ollagnon-Roman E, Lemainque A, Ruberg M, Brice A, Durr A (2004) Mutation in the catalytic domain of protein kinase C gamma and extension of the phenotype associated with spinocerebellar ataxia type 14. Arch Neurol 61:1242–1248. https://doi.org/10.1001/archneur.61.8.1242
doi: 10.1001/archneur.61.8.1242 pubmed: 15313841
Shirafuji T, Shimazaki H, Miyagi T, Ueyama T, Adachi N, Tanaka S, Hide I, Saito N, Sakai N (2019) Spinocerebellar ataxia type 14 caused by a nonsense mutation in the PRKCG gene. Mol Cell Neurosci 98:46–53. https://doi.org/10.1016/j.mcn.2019.05.005
doi: 10.1016/j.mcn.2019.05.005 pubmed: 31158466
Dosi C, Galatolo D, Rubegni A, Doccini S, Pasquariello R, Nesti C, Sicca F, Barghigiani M, Battini R, Tessa A, Santorelli FM (2020) Expanding the clinical and genetic heterogeneity of SPAX5. Ann Clin Transl Neurol 7:595–601. https://doi.org/10.1002/acn3.51024
doi: 10.1002/acn3.51024 pubmed: 32237276 pmcid: 7187698
Galatolo D, Kuo ME, Mullen P, Meyer-Schuman R, Doccini S, Battini R, Lieto M, Tessa A, Filla A, Francklyn C, Antonellis A, Santorelli FM (2020) Bi-allelic mutations in HARS1 severely impair histidyl-tRNA synthetase expression and enzymatic activity causing a novel multisystem ataxic syndrome. Hum Mutat 41:1232–1237. https://doi.org/10.1002/humu.24024
doi: 10.1002/humu.24024 pubmed: 32333447 pmcid: 7323910
Schmitz-Hübsch T, du Montcel ST, Baliko L, Berciano J, Boesch S, Depondt C, Giunti P, Globas C, Infante J, Kang JS, Kremer B, Mariotti C, Melegh B, Pandolfo M, Rakowicz M, Ribai P, Rola R, Schöls L, Szymanski S, van de Warrenburg BP, Dürr A, Klockgether T, Fancellu R (2006) Scale for the assessment and rating of ataxia: development of a new clinical scale. Neurology 66:1717–1720. https://doi.org/10.1212/01.wnl.0000219042.60538.92
doi: 10.1212/01.wnl.0000219042.60538.92 pubmed: 16769946
Anheim M, Fleury M, Monga B, Laugel V, Chaigne D, Rodier G, Ginglinger E, Boulay C, Courtois S, Drouot N, Fritsch M, Delaunoy JP, Stoppa-Lyonnet D, Tranchant C, Koenig M (2010) Epidemiological, clinical, paraclinical and molecular study of a cohort of 102 patients affected with autosomal recessive progressive cerebellar ataxia from Alsace, Eastern France: implications for clinical management. Neurogenetics 11:1–12. https://doi.org/10.1007/s10048-009-0196-y
doi: 10.1007/s10048-009-0196-y pubmed: 19440741
Riso V, Rossi S, Perna A, Nicoletti T, Bosco L, Zanni G, Silvestri G (2020) NGS-based detection of a novel mutation in PRKCG (SCA14) in sporadic adult-onset ataxia plus dystonic tremor. Neurol Sci 41:2989–2991. https://doi.org/10.1007/s10072-020-04443-0
doi: 10.1007/s10072-020-04443-0 pubmed: 32367327
Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL, Laboratory Quality Assurance Committee ACMG (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17:405–424. https://doi.org/10.1038/gim.2015.30
doi: 10.1038/gim.2015.30 pubmed: 25741868 pmcid: 4544753
Adachi N, Kobayashi T, Takahashi H, Kawasaki T, Shirai Y, Ueyama T, Matsuda T, Seki T, Sakai N, Saito N (2008) Enzymological analysis of mutant protein kinase Cgamma causing spinocerebellar ataxia type 14 and dysfunction in Ca2+ homeostasis. J Biol Chem 283:19854–19863. https://doi.org/10.1074/jbc.M801492200
doi: 10.1074/jbc.M801492200 pubmed: 18499672
Verbeek DS, Warrenburg BP, Hennekam FA, Dooijes D, Ippel PF, Verschuuren-Bemelmans CC, Kremer HP, Sinke RJ (2005) Gly118Asp is a SCA14 founder mutation in the Dutch ataxia population. Hum Genet 117:88–91. https://doi.org/10.1007/s00439-005-1278-z
doi: 10.1007/s00439-005-1278-z pubmed: 15841389
Wong MMK, Hoekstra SD, Vowles J, Watson LM, Fuller G, Németh AH, Cowley SA, Ansorge O, Talbot K, Becker EBE (2018) Neurodegeneration in SCA14 is associated with increased PKCγ kinase activity, mislocalization and aggregation. Acta Neuropathol Commun 6:99. https://doi.org/10.1186/s40478-018-0600-7
doi: 10.1186/s40478-018-0600-7 pubmed: 30249303 pmcid: 6151931
Ji J, Hassler ML, Shimobayashi E, Paka N, Streit R, Kapfhammer JP (2014) Increased protein kinase C gamma activity induces Purkinje cell pathology in a mouse model of spinocerebellar ataxia 14. Neurobiol Dis 70:1–11. https://doi.org/10.1016/j.nbd.2014.06.002
doi: 10.1016/j.nbd.2014.06.002 pubmed: 24937631
Chen C, Kano M, Abeliovich A, Chen L, Bao S, Kim JJ, Hashimoto K, Thompson RF, Tonegawa S (1995) Impaired motor coordination correlates with persistent multiple climbing fiber innervation in PKC gamma mutant mice. Cell 83:1233–1242. https://doi.org/10.1016/0092-8674(95)90148-5
doi: 10.1016/0092-8674(95)90148-5 pubmed: 8548809
Kano M, Hashimoto K, Chen C, Abeliovich A, Aiba A, Kurihara H, Watanabe M, Inoue Y, Tonegawa S (1995) Impaired synapse elimination during cerebellar development in PKC gamma mutant mice. Cell 83:1223–1231. https://doi.org/10.1016/0092-8674(95)90147-7
doi: 10.1016/0092-8674(95)90147-7 pubmed: 8548808
Ronsin S, Hannoun S, Thobois S, Petiot P, Vighetto A, Cotton F, Tilikete C (2019) A new MRI marker of ataxia with oculomotor apraxia. Eur J Radiol 110:187–192. https://doi.org/10.1016/j.ejrad.2018.11.035
doi: 10.1016/j.ejrad.2018.11.035 pubmed: 30599859
Hewamadduma CA, Hoggard N, O’Malley R, Robinson MK, Beauchamp NJ, Segamogaite R, Martindale J, Rodgers T, Rao G, Sarrigiannis P, Shanmugarajah P, Zis P, Sharrack B, McDermott CJ, Shaw PJ, Hadjivassiliou M (2018) Novel genotype-phenotype and MRI correlations in a large cohort of patients with SPG7 mutations. Neurol Genet 4:e279. https://doi.org/10.1212/NXG.0000000000000279
doi: 10.1212/NXG.0000000000000279 pubmed: 30533525 pmcid: 6244025
Cocozza S, Pontillo G, De Michele G, Perillo T, Guerriero E, Ugga L, Salvatore E, Galatolo D, Riso V, Saccà F, Quarantelli M, Brunetti A (2020) The “crab sign”: an imaging feature of spinocerebellar ataxia type 48. Neuroradiology 62:1095–1103. https://doi.org/10.1007/s00234-020-02427-7
doi: 10.1007/s00234-020-02427-7 pubmed: 32285148
Pieperhoff P, Schmitz-Hubsch T, Scheel M, Ronnefarth M, Doss S, Schlapakow E, Synofzik M, Schols M, Klockgether T, Shah NJ, Paul F, Deistung A, Amunts K, Greschus S, Timmann D, Minnerop M (2020) The T2 Hyperintense Dentate Sign-in different neurodegenerative cerebellar ataxias, Poster, SCA global 2020
Nolte D, Landendinger M, Schmitt E, Müller U (2007) Spinocerebellar ataxia 14: novel mutation in exon 2 of PRKCG in a German family. Mov Disord 22:265–267. https://doi.org/10.1002/mds.21269
doi: 10.1002/mds.21269 pubmed: 17149711
Vlak MH, Sinke RJ, Rabelink GM, Kremer BP, van de Warrenburg BP (2006) Novel PRKCG/SCA14 mutation in a Dutch spinocerebellar ataxia family: expanding the phenotype. Mov Disord 21:1025–1028. https://doi.org/10.1002/mds.20851
doi: 10.1002/mds.20851 pubmed: 16547918
Yabe I, Sasaki H, Chen DH, Raskind WH, Bird TD, Yamashita I, Tsuji S, Kikuchi S, Tashiro K (2003) Spinocerebellar ataxia type 14 caused by a mutation in protein kinase C gamma. Arch Neurol 60:1749–1751. https://doi.org/10.1001/archneur.60.12.1749
doi: 10.1001/archneur.60.12.1749 pubmed: 14676051
Dalski A, Mitulla B, Bürk K, Schattenfroh C, Schwinger E, Zühlke C (2006) Mutation of the highly conserved cysteine residue 131 of the SCA14 associated PRKCG gene in a family with slow progressive cerebellar ataxia. J Neurol 253:1111–1112. https://doi.org/10.1007/s00415-006-0209-9
doi: 10.1007/s00415-006-0209-9 pubmed: 16649092
Yamashita I, Sasaki H, Yabe I, Fukazawa T, Nogoshi S, Komeichi K, Takada A, Shiraishi K, Takiyama Y, Nishizawa M, Kaneko J, Tanaka H, Tsuji S, Tashiro K (2000) A novel locus for dominant cerebellar ataxia (SCA14) maps to a 10.2-cM interval flanked by D19S206 and D19S605 on chromosome 19q13.4-qter. Ann Neurol 48:156–163. https://doi.org/10.1002/1531-8249(200008)48:2%3c156::aid-ana4%3e3.0.co;2-9
doi: 10.1002/1531-8249(200008)48:2<156::aid-ana4>3.0.co;2-9 pubmed: 10939565

Auteurs

Giovanna De Michele (G)

Department of Neurosciences, Reproductive and Odontostomatological Sciences, Federico II University, Via Sergio Pansini 5, 80131, Naples, Italy.

Daniele Galatolo (D)

Istituto Di Ricovero E Cura a Carattere Scientifico (IRCCS), Fondazione Stella Maris, Pisa, Italy.

Serena Galosi (S)

Department of Human Neuroscience, Sapienza University of Rome, Rome, Italy.

Andrea Mignarri (A)

Department of Medicine, Surgery and Neuroscience, Neurology and Neurometabolic Unit, University of Siena, Siena, Italy.

Gabriella Silvestri (G)

Department of Neurosciences, Faculty of Medicine and Surgery, Catholic University of Sacred Heart, Rome, Italy.
Neurology Unit, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy.

Carlo Casali (C)

Department of Medical and Surgical Sciences and Biotechnologies, Sapienza University of Rome, Rome, Italy.

Vincenzo Leuzzi (V)

Department of Human Neuroscience, Sapienza University of Rome, Rome, Italy.

Ivana Ricca (I)

Istituto Di Ricovero E Cura a Carattere Scientifico (IRCCS), Fondazione Stella Maris, Pisa, Italy.

Melissa Barghigiani (M)

Istituto Di Ricovero E Cura a Carattere Scientifico (IRCCS), Fondazione Stella Maris, Pisa, Italy.

Alessandra Tessa (A)

Istituto Di Ricovero E Cura a Carattere Scientifico (IRCCS), Fondazione Stella Maris, Pisa, Italy.

Ettore Cioffi (E)

Department of Medical and Surgical Sciences and Biotechnologies, Sapienza University of Rome, Rome, Italy.

Caterina Caputi (C)

Department of Human Neuroscience, Sapienza University of Rome, Rome, Italy.

Vittorio Riso (V)

Department of Neurosciences, Faculty of Medicine and Surgery, Catholic University of Sacred Heart, Rome, Italy.
Neurology Unit, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy.

Maria Teresa Dotti (MT)

Department of Medicine, Surgery and Neuroscience, Neurology and Neurometabolic Unit, University of Siena, Siena, Italy.

Francesco Saccà (F)

Department of Neurosciences, Reproductive and Odontostomatological Sciences, Federico II University, Via Sergio Pansini 5, 80131, Naples, Italy.

Giuseppe De Michele (G)

Department of Neurosciences, Reproductive and Odontostomatological Sciences, Federico II University, Via Sergio Pansini 5, 80131, Naples, Italy.

Sirio Cocozza (S)

Department of Advanced Biomedical Sciences, Federico II University, Naples, Italy.

Alessandro Filla (A)

Department of Neurosciences, Reproductive and Odontostomatological Sciences, Federico II University, Via Sergio Pansini 5, 80131, Naples, Italy. afilla@unina.it.

Filippo M Santorelli (FM)

Istituto Di Ricovero E Cura a Carattere Scientifico (IRCCS), Fondazione Stella Maris, Pisa, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH